Outlook Therapeutics, Inc. (OTLK) — SC 13D/A Filings
All SC 13D/A filings from Outlook Therapeutics, Inc.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Syntone Ventures LLC Amends Stake in Outlook Therapeutics
— Apr 17, 2024 Risk: medium
Syntone Ventures LLC, through an amendment filed on April 17, 2024, has updated its Schedule 13D regarding Outlook Therapeutics, Inc. The filing indicates a cha -
GMS Ventures & Investments Amends Outlook Therapeutics Filing
— Mar 20, 2024 Risk: medium
GMS Ventures & Investments, through Ghiath M. Sukhtian, has amended its Schedule 13D filing for Outlook Therapeutics, Inc. on March 20, 2024. This filing indica -
Tenshi Healthcare Amends Outlook Therapeutics Stake (19th Update)
— Jan 31, 2024
Tenshi Healthcare Pte. Ltd. filed an Amendment No. 19 to its Schedule 13D on January 31, 2024, indicating a change in its beneficial ownership of Outlook Therap
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX